Effect of glucosamine on virus production and antigen expression in avian sarcoma virus-transformed cells

Insights

Glucosamine treatment halts avian sarcoma virus replication in chicken cells, preventing infectious virus production. However, non-infectious viral particles can still form, and glucosamine impacts cell antigen expression.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Avian sarcoma virus transforms chicken embryo fibroblast (CEF) cells.
  • Viral particle synthesis and infectivity are key aspects of viral replication.
  • Cellular immune responses and antigen expression are crucial in viral infections.

Purpose of the Study:

  • To investigate the effect of glucosamine on avian sarcoma virus replication in CEF cells.
  • To determine if glucosamine affects the production of infectious viral particles.
  • To assess the impact of glucosamine on antigenic expression and cell-mediated immunity in transformed CEF cells.

Main Methods:

  • Treatment of CEF cells with glucosamine.
  • Analysis of progeny-transforming virus particle formation.
  • Detection of non-infectious physical particles containing viral RNA and RNA-dependent DNA polymerase.
  • Indirect immunofluorescence assay for antigenic expression.
  • Lymphocyte stimulation assay for cell-mediated immunity.

Main Results:

  • Glucosamine completely inhibited the formation of progeny-transforming virus particles.
  • Non-infectious physical particles containing viral RNA and RNA-dependent DNA polymerase were synthesized when glucose was present during glucosamine exposure.
  • Glucosamine treatment affected antigenic expression in transformed CEF cells.
  • A lesser inhibition was observed in a lymphocyte stimulation assay for cell-mediated immunity.

Conclusions:

  • Glucosamine is a potent inhibitor of infectious avian sarcoma virus production.
  • Glucosamine's effect on viral particle synthesis is dependent on the presence of glucose.
  • Glucosamine influences the antigenic profile of transformed CEF cells and has a limited impact on cell-mediated immunity.